NCT07081841 - AB-1005 Long-Term Follow-up Study | Biotech Hunter

Enrollment

132

Participants

Timeline

Start Date

September 4, 2025

Primary Completion Date

September 30, 2037

Study Completion Date

March 30, 2038

Conditions

Parkinson's DiseaseMultiple System Atrophy, Parkinson Variant

Interventions

OTHER

Observation

This is an observational study in which safety laboratories and non-invasive routine clinical assessments are conducted to gauge long term safety and efficacy.

Trial Locations (2)

43210

Ohio State University, Columbus

94143

University of California San Francisco, San Francisco